A multi-cohort phase I/IIa clinical trial to evaluate the safety, tolerability, and pharmacokinetics of TST001 administered as a monotherapy, with nivolumab or standard of care in patients with locally advanced or metastatic solid tumors: TransStar101 Meeting Abstract
| Authors: | Janjigian, Y. Y.; Sun, W.; Rocha Lima, C. M. S. P.; Shah, S.; Scott, A. J.; Monga, D. K.; Kundranda, M. N.; Sher, A. F.; Gold, P. J.; Berlin, J.; Patel, M. R.; Alese, O. B.; Hamilton, E. P.; Cecchini, M.; Van Tine, B. A.; George, B.; Mehta, R.; Xia, Z.; Germa, C.; Gabrail, N. Y. |
| Abstract Title: | A multi-cohort phase I/IIa clinical trial to evaluate the safety, tolerability, and pharmacokinetics of TST001 administered as a monotherapy, with nivolumab or standard of care in patients with locally advanced or metastatic solid tumors: TransStar101 |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.TPS4176 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: TPS4176 -- Meeting was also available virtually -- Source: Cinahl |
